Sector News

Linde posts earnings gain on strong pricing, cost savings

May 7, 2020
Chemical Value Chain

Industrial gases maker Linde plc reported first-quarter 2020 income from continuing operations of $573 million, up 11% year-on-year (YOY) on operating leverage from broad-based price increases and cost savings.

Net sales were $6.7 billion, down 3% YOY on negative currency impacts and energy cost pass through. Reported adjusted earnings were $1.89/share, up 12% YOY and 6 cts ahead of consensus analyst estimates. Volume was down 1% YOY and 4% sequentially, led by timing of engineering projects and COVID-19 impacts.

Americas sales of $2.7 billion were down 1% YOY. Americas operating profit was $661 million, up 13% YOY. Americas segment volumes were up 2% YOY led by healthcare and food and beverage markets. Segment operating profit was higher on price increases and cost savings.

Europe, Middle East & Africa (EMEA) sales of $1.6 billion were down 3% YOY. Operating profit of $355 million was up 2%. Volumes were down 1% YOY on weaker EMEA industrial production. Profit was higher on price gains and cost savings.

Asia Pacific segment sales of $1.3 billion were 6% lower YOY. Operating profit of $281 million was up 3% YOY. Volumes were down 5% YOY due to COVID-19 impacts and an equipment sale included in prior-year results. Margins were higher on price and cost savings.

Engineering segment sales were $608 million down, 4% YOY. Operating profit was $91 million, up 17% YOY. Sales were lower on project timing but margins were high on strong project execution and productivity, Linde said.

Outlook scenarios

Linde cut its 2020 outlook due to COVID-19 impacts, updating its forecast with two different scenarios. Assuming early-third-quarter recovery, the company expects a mid-to-high single-digit earnings per share (EPS) gain. In a more bearish mid-fourth-quarter recovery scenario, the company expects flat EPS to a low-single-digit decline. The company previously forecast 2020 EPS growth of 10-13%.

Linde will cut planned 2020 base capital expenditures by $400 million, to $3 billion-$3.4 billion. “While it is very difficult to predict the future impact, I have full confidence in our ability to continue to create shareholder value given our resilient business model and inherent opportunities to mitigate macroeconomic headwinds,” said Linde president and CEO Steve Angel.

By: Robert Westervelt

Source: Chemical Week

comments closed

Related News

July 3, 2022

Neste acquires European rights to Alterra’s chemical recycling tech for difficult plastics

Chemical Value Chain

Neste has bought the European rights for Alterra Energy’s liquefaction technology, strengthening its chemical recycling capabilities. Alterra is a US-based company that has developed a thermochemical solution for liquefying difficult-to-recycle plastics.

July 3, 2022

Maria Soler Nunez appointed as Head, Group Operations at Lonza

Chemical Value Chain

Lonza appoints Maria Soler Nunez as Head, Group Operations. Maria joins Lonza from Novartis where she has led the quality organization since 2020. Maria will commence her tenure with Lonza Group on 1 August 2022, succeeding Stefan Stoffel, who is retiring from Lonza.

July 3, 2022

AkzoNobel announces Gregoire Poux-Guillaume as new Chief Executive Officer as of November 1, 2022

Chemical Value Chain

AkzoNobel has announced that Gregoire Poux-Guillaume will become the company’s new Chief Executive Officer (CEO) as of November 1, 2022. He will succeed Thierry Vanlancker, who has been CEO and member of the Board of Management since 2017, and whose term of office is coming to an end.